Pricing Log in Create free account

Cue Biopharma, Inc. (CUE) vs Satellos Bioscience Inc. (MSLE)

Cue Biopharma, Inc. and Satellos Bioscience Inc. are both Biotechnology companies. Cue Biopharma, Inc. and Satellos Bioscience Inc. are of similar size ($145.1M and $135.6M). Satellos Bioscience Inc. has the higher net margin (0.00% vs −435.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Satellos Bioscience Inc. leads on 10 and Cue Biopharma, Inc. on 1.

Valuation

Metric CUE MSLE Biotechnology median
P/E n/m n/m 8.42
P/S 3.14 n/m 10.01
P/B 51.25 2.38 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 2.73 n/m 9.41
Earnings yield (144.73%) (28.07%) (31.85%)
Free cash flow yield (42.34%) (20.36%) (24.58%)

Profitability

Metric CUE MSLE Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (262.03%) 0.00% 0.00%
Net margin (435.83%) 0.00% 0.00%
Free cash flow margin (133.13%) 0.00% 0.00%
Return on equity (1,603.48%) (70.45%) (56.36%)
Return on assets (459.60%) (64.76%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CUE MSLE Biotechnology median
Revenue growth (TTM) 354.37% — 6.02%
EPS growth (last fiscal year) 61.11% 21.20% 30.26%
Revenue growth, 5-year CAGR 54.16% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CUE MSLE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 11.22 4.72
Net debt to EBITDA 1.10 1.05 0.96

Dividend

Metric CUE MSLE Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CUE MSLE Biotechnology median
Market cap 135.63m 145.14m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack